FDA Greenlights a CRISPR-Based Test to Diagnose Covid-19

The test gives a result within an hour

A test that can diagnose the coronavirus within an hour using the gene-editing technology known as CRISPR has received emergency use authorization from the U.S. Food and Drug Administration.

The test was developed by Sherlock Biosciences, a biotech company launched in March 2019…

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Emily Mullin

Former staff writer at Medium, where I covered biotech, genetics, and Covid-19 for OneZero, Future Human, Elemental, and the Coronavirus Blog.